Bayer to fight 'resolutely' US claims against Cipro patent

Bayer AG said it will "resolutely" fight several legal claims that have emerged in the US against the validity of its patent on anti-anthrax drug Cipro.

Bayer to fight 'resolutely' US claims against Cipro patent

Bayer AG said it will "resolutely" fight several legal claims that have emerged in the US against the validity of its patent on anti-anthrax drug Cipro.

In a statement, Bayer said that its patent on Cipro "is not in question" until it runs out in 2003.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited